Back
Thryv Holdings Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
32
THRY
Thryv Holdings
Last Price:
14.51
Seasonality Move:
23.76%
Buy
97
RYTM
Rhythm Pharmaceuticals
Last Price:
64.04
Seasonality Move:
9.98%
Sell
32
Thryv Holdings (THRY)
is a Sell
Is Thryv Holdings a Buy, Sell or Hold?
- The current Thryv Holdings [THRY] share price is $14.90. The Score for THRY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- THRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
97
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $65.58. The Score for RYTM is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
THRY Stock Price Chart
What is Thryv Holdings's stock price today?
-
The Thryv Holdings share price today is $14.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $65.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
THRY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.7 | Sell |
Relative Strength Index (14 RSI): | 39.69 | Sell |
Chaikin Money Flow: | 481368 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.14 - 17.68) | Sell |
Bollinger Bands (100): | (16.38 - 18.6) | Sell |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.64 | Buy |
Relative Strength Index (14 RSI): | 75.47 | Buy |
Chaikin Money Flow: | -747845 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.34 - 58.08) | Buy |
Bollinger Bands (100): | (43.86 - 53.38) | Buy |
THRY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.9 | Sell |
20-day SMA: | 16.3 | Sell |
50-day SMA: | 17.07 | Sell |
200-day SMA: | 19.49 | Sell |
8-day EMA: | 15.18 | Sell |
20-day EMA: | 15.93 | Sell |
50-day EMA: | 16.81 | Sell |
200-day EMA: | 18.72 | Sell |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.17 | Buy |
20-day SMA: | 53.22 | Buy |
50-day SMA: | 51.3 | Buy |
200-day SMA: | 45.17 | Buy |
8-day EMA: | 60.15 | Buy |
20-day EMA: | 55.23 | Buy |
50-day EMA: | 51.77 | Buy |
200-day EMA: | 44.82 | Buy |
Thryv Holdings Earnings Growth & THRY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.61 per share, and an increase next year of $0.72 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Thryv Holdings Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |